References
Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267–1284
Mason EO, Lamberth LB, Kaplan SL (1996) In vitro activities of oxazolidones U-100592 and U-100766 against penicillin-resistant and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 40:1039–1040
Spangler SK, Jacobs MR, Appelbaum PC (1996) Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 40:481–484
Moellering RC (2003) Linezolid: the first oxazolidone antimicrobial. Ann Intern Med 138:135–142
Diekema DI, Jones RN (2000) Oxazolidinones: a review. Drugs 59:7–16
Cottagnoud P, Gerber CM, Acosta F, Cottagnoud M, Neftel K, Tauber MG (2000) Linezolid against penicillin-sensitive and penicillin-resistant pneumococci in the rabbit meningitis model. J Antimicrob Chemother 46:981–985
Faella F, Pagliano P, Fusco U, Attanasio V, Conte M (2006) Combined treatment with ceftriaxone and linezolid of pneumococcal meningitis: a case series including penicillin-resistant strains. Clin Microbiol Infect 12:391–394
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramírez, P., Sahuquillo, J.M., Cortés, C. et al. Linezolid as rescue therapy for pneumococcal meningitis. Intensive Care Med 33, 924–925 (2007). https://doi.org/10.1007/s00134-007-0557-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-007-0557-7